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ABSTRACT 
Fast-dissolving drug-delivery systems (FDDS) serve a major benefit over the conventional dosage forms because the drug gets disintegrated 
rapidly and dissolves in the saliva without the use of water. Lisinopril is the lysine analog of enalapril which was used to treat hypertension and 
symptomatic congestive heart failure, to improve survival in certain individuals after myocardial infarction and to prevent the progression of 
renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy. The drug is found to be absorbed 
slowly and incompletely from the gastrointestinal tract (oral) bioavailability of the drug is ∼25% in order to increase bio availability lisinopril 
was formulated as fast dissolving sublingual film A total of 10 formulations of Fast dissolving sublingual film of lisinopril was prepared by using 
different polymers like HPMC E15, HPMCE5, HPMC E3, HPMC K 15, PVP, PEG 400 as plasticizer, SSG as a super disintegrant. Among them F10 
formulation containing HPMC E 3 and PVP in combination of 4:1 ratio with SSG as a super disintegrant showed 95.69 % drug released in 10 
minutes and which was disintegrated in 95 sec . 
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INTRODUCTION 
Fast dissolving sublingual films 
The concept of sublingual films has been introduced to 
overcome the problems associated with conventional oral 
dosage forms and improve bioavailability there by 
optimization of therapy. 
Fast dissolving films are most advance form of solid dosage 
form due to flexibility. It improve efficacy of active 
pharmaceutical ingredient [API] dissolving in short duration 
oral cavity after the contact with less amount of saliva as 
compared to dissolving tablet.¹ 
Ideal characteristics for a drug to formulate it into 
sublingual film²: 
 The drug should have pleasant taste. 
 The drug that is incorporated should have low dose up 
to 40mg. 
 The drug with smaller and moderate molecular weight 
is preferable. 
 The drug should have good stability and solubility in 
water as well as in saliva  
 It should be have partially unionized at the pH of oral 
cavity. 
 It should have the ability to permeate oral mucosal 
tissues.  
Advantages of sublingual film 3, 4, 5: 
 No risk of chocking. 
 Convenient dosing or accurate dosing. 
 No need of water to swallow or chew. 
 Rapid onset of action. 
 Easy of handling & transportation. 
 Enhanced stability. 
 Taste masking. 
Half life of Lisinopril is 12 hr. The daily doses ranges from 20 
to 80 mg. The systemic bioavailability of Lisinopril is 
approximately 25%. In view of these facts this drug can be 
considered as a suitable candidate for fast dissolving oral 
film. In this study an attempt is made to investigate the 
feasibility of fast dissolving oral films as a medium for the 
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fast delivery of Lisinopril with better bioavailability and 
enhanced patient compliance. 
MATERIALS 
All the materials used in this study (Lisinopril, HPMC E15, 
HPMCE5, HPMC E3, HPMC K 15, PVP, SLS, SSG, PEG 400, 
Sucralose, Peppermint oil, Citric acid) were obtained from 
Sree srinivasa scientifics, Hyderabad 
METHODOLOGY 
Preparation of fast dissolving sublingual films6-10:  
Fast dissolving sublingual film was prepared by solvent 
casting method. A total of 10 formulations were prepared by 
using different polymers, super disintegrating agent, 
plasticizer in combination. Total water was divided into two 
parts in one part drug is dissolved and in other part polymer, 
plasticizer, super disintegrant and flavouring agents were 
dissolved. Part one is added to the part two with stirring and 
sonicated for 10 mins to remove the entrapped air, the 
solution was poured into petridish and an inverted funnel 
was placed over it. Kept for evapouration for 24 hours. The 
formed patch was removed and analyzed. 
 
Table 1: Formulation Design 
Excipient  Formulation code 
 F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
Drug (mg) 40 40 40 40 40 40 40 40 40 40 
HPMC E15(mg) 500  - - - - - - - - - 
HPMCE5 (mg) - 500 - - 300 - 400 - - - 
HPMC E3 (mg) - - 500  - 300 - 400 400 400 
HPMC K 15 
M(mg) 
- - - 500 - - - - - - 
PVP (mg) - - - - 200 200 100 100 100 100 
SLS  (mg) 2 2 2 2 2 2 2 2 2 2 
SSG (mg) - - - - - - - 10  20  30 
PEG 400 (ml) 2 2 2 2 2 2 2 2 2 2 
Sucralose (mg) 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 50 mg 
Peppermint oil 
(ml) 
0.3ml 0.3ml 0.3ml 0.3ml 0.3ml 0.3ml 0.3ml 0.3ml 0.3ml 0.3ml 
Citric acid (mg) 70 mg 70 mg 70 mg 70 mg 70 mg 70 mg 70 mg 70 mg 70 mg 70 mg 
Water upto (ml) 15 15 15 15 15 15 15 15 15 15 
 
 
Evaluation studies 
Preparation of standard solution: 
Method: 
The pure drug of about 10 mg was weighed and transferred 
in to a 10ml volumetric flask. The drug was dissolved 
completely in a few ml of 0.1N NaOH and made up to the 
final volume with NaOH to get a stock solution of 
concentration 1000μg/ml. Aliquots of standard stock 
solution were pipette out and diluted suitably with water to 
get the final concentration of standard solutions. 
Absorption maxima method: 
The solutions were scanned in the range of 400-200 nm 
against 0.1N NaOH as reference, and the peaks were 
observed in the spectra at 218nm. The wavelength selected 
for analysis of drug was 218nm. The drug obeys the lamberts 
law in the range of 2-12 μg/ml. By using linearity plot the 
quantification was carried out. 
 Compatibility studies by FTIR 
 The drug and excipient compatibility studies were carried 
out by FTIR study.  
 Thickness: 
 The thickness of the patch was measured using digital 
VernierCalliper with a least count of 0.01 mm at different 
spots of the film. The thickness was measured at three 
different spots of the patch and average was taken and SD 
was calculated. 
 
 
Weight variation: 
Four centimeter square of the film was cut at three different 
places from the casted film. The weight of each film was 
taken and weight variation was calculated 
Folding endurance: 
 Folding endurance was determined by repeated folding of 
the film at the same place till the strip breaks. The number of 
times the film is folded without breaking was computed as 
the folding endurance value. 
Tensile strength: 
Tensile strength is the maximum stress applied to a point at 
which the film specimen breaks. It is calculated by the 
applied load at rupture divided by the cross-sectional area of 
the film as given below: 
Tensile strength = Load at failure ×100/ Film thickness × film 
width 
Percent elongation: 
Film sample stretches when stress is applied and it is 
referred to as strain.Strainis basically the deformation of film 
divided by original dimension of the sample. Elongation of 
film increases as the plasticizer content increases. 
Percent Elongation= L * 100/ Lo 
Where, L = Increase in length of film, 
                Lo = Initial length of film. 
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Surface pH: 
The film to be tested was placed in a petri dish and was 
moistened with0.5ml of distilled water and kept for 
30sec.The pH was noted after bringing the electrode of the 
pH meter in contact with the surface of the formulation and 
allowing equlibriation for 1min. The average of three 
determinations for each formulationwas done. 
Uniformity of drug content  
This parameter was determined by dissolving one film of 
dimension 2 x 2 cm by homogenization in 100 ml of 
stimulated saliva of pH 6.8 for 30 min with continuous 
shaking. . From this, 10 ml was diluted to 50 ml with 
simulated salivary fluid. The absorbance was measured 
using an UV spectrophotometer. The experiments were 
carried out in triplicate for the films of all formulations and 
average values were recorded. 
In Vitro permeation studies through egg membrane: 
Permeation studies were carried using the modified Franz 
diffusion cell of internal diameter of 2.5 cm. The egg 
membrane was separated by using concn HCL then washed 
in isotonic phosphate buffer of pH 6.8 and used immediately. 
The egg membrane was mounted between the donor and 
receptor compartments. The receptor compartment was 
filled with 25 mL of isotonic phosphate buffer of pH 6.8. 
Which was maintained at 37 ± 0.2ºC and the hydrodynamics 
were maintained by stirring with a magnetic bead at 50 rpm. 
One film of dimensions 2 x 2 cm, previously weighed, was 
placed in intimate contact with the mucosal surface of the 
membrane that was previously moistened with a few drops 
of simulated saliva. The donor compartment was filled with 
1 mL of simulated saliva of pH 6.8. Samples 
RESULTS AND DISCUSSION 
Table 2: Standard graph of lisinopril pure drug 
Concentration (μg/ml) Absorbance 
0 0 
2 0.211 
4 0.403 
6 0.575 
8 0.790 
10 0.964 
12 1.211 
 
 
Compatibility studies by FTIR: 
The study showed peaks for the corresponding functional 
groups in Lisinopril. When the study was carried out with 
the combination of Lisnopril and polymers, there were no 
major changes in the peaks. Hence there was no interaction 
with the polymers. The results were shown below 
 
Table 3: Results of FTIR studies 
Ftir spectra Peak of Functional groups [Wave length (cm-1)]  
 C-H Stretching 
(alkane) 
C-H Bending 
(aromatic) 
C=O 
Stretching 
(Phenols)  
C=O 
Stretching 
(Amide) 
C=C 
Stretching 
(Aromatic) 
Pure drug  2925.3 749.27 1395 1656.38 1590  
Final Formulation 2900 750 1400 1659.12 1590 
 
   
FTIR of lisinopril of pure drug                       FTIR of Final formulation 
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Preparation of Fast dissolving sublingual patches: 
Initially fast dissolving sublingual patches were optimized 
with an intention to get good physical properties by 
employing plasticizer in different concentrations. Film 
forming polymers used in the present investigation were 
HPMC and PVP different grades in different concentrations. 
The plasticizer Propylene glycol (10, 15, 20&25%W/W) were 
studied. Propylene glycol (20%) W/W Concentration gave 
good physical properties like flexibility, elasticity and 
transparency. Plasticization with Propylene glycol provided 
higher strength and better elongation characters to the 
films. The reason attributed to this is as the major parts of 
the films were HPMC which is hydrophilic polymer, the 
hydrophilic plasticizer Propylene glycol could reduce the 
glass transition temperature of the film. After getting a 
desired flexible film different concentration of super 
disintegrants was employed in order to achieve fast 
dissolution. 
 
 
Table 4: Result of Evaluation Parameters of Batch F1-F10 
Formulation 
Code 
Thickness (mm) Weight 
(mg) 
Folding 
endurance 
Tensile strength 
(N/ mm2) 
% Elongation % Moisture 
content 
F1  0.10 ± 0.020 51 ± 1.00 > 300 5.2 ± 0.03 28.5 ± 0.11 3 ± 0.957 
F2 0.12 ± 0.005 53 ± 1.00 > 300 6.8 ± 0.01 32.3 ± 0.08 4 ± 0.942 
F3 0.11 ±0.011 52 ± 1.00 > 300 7.1 ± 0.05 35.0 ± 0..16 3 ± 0.642 
F4 0.09 ± 0.005 49 ± 1.00 152 4.2 ± 0.10 18.0 ± 0.12 5 ± 0.744 
F5 0.16 ± 0.010 56 ± 1.40 209 3.6 ± 0.13 19.0 ± 0.32 4 ± 0.956 
F6 0.15 ± 0.005 55 ± 1.15 >300 8.6 ± 0.04 40.6 ± 0.10 4 ± 0.749 
F7 0.10 ± 0.005 51 ± 0.57 124 4.0 ± 0.10 12.1 ± 0.13 7 ± 0.442 
F8 0.12 ± 0.010 54 ± 1.00 > 300 4.4 ± 0.10 27.3 ± 0.09 6 ± 0.882 
F9 0.15 ± 0.005 54 ± 1.53 > 300 5.9 ± 0.06 29.4 ± 0.14 5 ± 0.242  
F10 0.12 ± 0.05 56 ± 1.20 > 300 7.1 ± 0.05 35.0 ± 0..16 4 ± 0.603 
 
Table 5: Result of Evaluation Parameters of Batch F1-F10 
Formulation Code Surface pH Disintegration time (s) Drug content (%) 
F1  6.63 ± 0.05 192 ± 3.00 85.67 
F2 6.61 ± 0.04 162 ± 1.00 90.23 
F3 6.63 ± 0.02 168 ± 2.00 91.38 
F4 7.01 ± 0.01 160± 2.00 87.96 
F5 6.68 ± 003 130 ± 1.40 89.59 
F6 7.04 ± 0.01 202 ± 1.15 90.42 
F7 6.53 ± 0.03 177 ± 5.00 91.5 
F8 7.08 ± 0.02 125 ± 2.00 92.91 
F9 6.41 ± 0.03 121 ± 5.00 92.82 
F10 6.63 ± 0.02 95 ± 2.53 95.69 
 
Discussion of evaluation parameters of Fast dissolving 
sublingual films; 
Physical appearance: All the sublingual films were visually 
inspected for colour, clarity, flexibility. 
a. Weight of the film  
Drug loaded films (2x2 cm2) were tested for uniformity of 
weight. The films were found uniform. The average weight of 
the film was found to be in the range of 51 ± 1.00 to 56 ± 
1.20mg. as the polymer content increase, the weight of the 
patch also increased.  
b. Thickness of the film 
All the films have uniform thickness throughout. Average 
thickness was found to be in the range of 0.10 ± 0.005 to 0.16 
± 0.010 mm. As the polymeric content increases, the 
thickness of the patch also increases.  
c. Moisture content  
Moisture content in F1 to F10 were found to be in the range 
of 3 to 7%.  
 
 
d. Drug content determination  
It was determined for all formulation by UV 
spectrophotometer method shown in table. The data 
obtained from triplicate studies were analyzed for mean and 
standard deviation. The results of content uniformity 
indicated that the drug was uniformly dispersed. Recovery 
was possible to the tune of 85.67 to 95.69 %. 
e. Tensile strength  
Ideal sublingual film should be flexible, elastic and strong 
enough to withstand breakage due to stress caused during 
its residence in the mouth. The tensile strength shows the 
strength and elasticity of the film. A soft and weak polymer is 
characterized by low TS; a hard and brittle polymer is 
defined by a moderate TS, a soft and tough polymer is 
characterized by a moderate TS, whereas a hard and tough 
polymer is characterized by high TS. Tensile Strength 
increased with the increase in polymeric content. Maximum 
TS was exhibited by F6 batch (8.6 ± 0.04 kg/cm2) and 
minimum was exhibited by F5 batch (3.6 ± 0.13 kg/cm2).  
f. Folding endurance  
Folding endurance measures the ability of film to withstand 
rupture. Patch did not show any cracks even after folding for 
more than 300 times. Hence it was taken as the end point. 
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Folding endurance did not vary when the comparison was 
made between plain patch and drug loaded patch. 
In-vitro diffusion studies: 
The percentage amount of drug diffusion is plotted against 
time to obtain the diffusion profile. It was found that in 10 
min, the entire quantity of the released drug from the 
formulation diffused completely and hence indicated a good 
diffusion coefficient, which is essential for faster onset of 
action. Formulation F4 showed minimum drug release 
(41.71 %) and F10 Formulation showed a maximum drug 
release of (95.69%). 
 
Table 6: In-vitro drug diffusion data 
Time in mins F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
0 0 0 0 0 0 0 0 0 0 0 
2 40.12 54.5 56.5 15.9 58.5 55.6 59.6 60.12 62.8 65.9 
4 65.3 67.5 75.5 27.5 68.2 70.12 72.15 74.5 78.5 80.5 
8 74.7 80.5 89.5 30.31 80.81 81.5 86.5 87.5 88.5 90.12 
10 85.67  90.23  91.38  41.71  89.59  90.42  91.5 92.91 92.82  95.69 
 
 
Figure 1: Comparisons of drug release of formulations 
F1,F2,F3 
 
 
Figure 2: Comparisons of drug release of formulations 
F4,F5,F6 
 
Figure 3: Comparisons of drug release of formulations 
F7,F8. 
 
 
Figure 4: Comparisons of drug release of formulations 
F9,F10
 
Stability studies: 
Stability studies were carried out for 45 days at 2-8°C (45% 
RH) and 25-30°C (60% RH). The films were observed for 
physical changes, the percentage drug content and the 
percentage drug release. Fast-dissolving films of lisinopril 
were found to be physically and chemically stable and 
showed no significant change in terms of physical 
characteristics, the percentage drug content and the 
percentage drug release. 
 
Table 7: Stability studies data 
S.No Time in Days Appearence In –Vitro disintegration 
time 
%CDR 
1 Intial (0 Days) Transparent and Acceptable 95 ± 2.53 95.69 
2 1 month (30 Days) Transparent and Acceptable 95 ± 4.25 94.98 
3 3 months (90 days) Transparent and Acceptable 95 ± 5.46 94.85 
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CONCLUSION 
Fast-dissolving drug-delivery systems (FDDS) serve a major 
benefit over the conventional dosage forms because the drug 
gets disintegrated rapidly and dissolves in the saliva without 
the use of water. Lisinopril is the lysine analog of enalapril 
which was used to treat hypertension and symptomatic 
congestive heart failure, to improve survival in certain 
individuals after myocardial infarction and to prevent the 
progression of renal disease in hypertensive patients with 
diabetes mellitus and microalbuminuria or overt 
nephropathy. The drug is found to be absorbed slowly and 
incompletely from the gastrointestinal tract (oral) 
Bioavailability of the drug is ∼25% inorder to increase bio 
availability lisinopril was formulated as fast dissolving 
sublingual film .A total of 10 formulations of Fast dissolving 
sublingual film of lisinopril was prepared by using  different  
polymers like HPMC E15, HPMCE5, HPMC E3, HPMC K 15, 
PVP, plasticizer PEG 400, SSG as a super disintegrant .Among 
them F10 formulation containg HPMC E 3 and PVP in 
combination of 4:1 ratio with SSG as a super disintegrant 
showed 95.69 % drug released in 10 mins and which was 
disintegrated in 95 sec. The optimized formulation was kept 
for stability studies no significant changes were observed 
after 3 month in the disintegration time and drug content. 
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